"Five patients received the treatment in a pilot study conducted by doctors at Imperial College Healthcare NHS Trust and scientists at Imperial College London.
The therapy was found to be safe, and all the patients showed improvements in clinical measures of disability.
The findings are published in the journal Stem Cells Translational Medicine. It is the first UK human trial of a stem cell treatment for acute stroke to be published."
It's ALL happening in front of our eyes. SVFC could Potentially be HUGE IMO
Stem Cell Therapy is a GLOBAL Phenomena Evolving and SVFC is Well-Advised to FOCUS FIRST NATIONALLY in the United States and also keep in View Additions of Centers Internationally, starting perhaps with Australia, Korea, or Abu Dhabi where the CEO has Established Connections:)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.